Mycobacterium leprae

Last updated: November 01, 2022

Mycobacterium leprae

CONA CM

CONA CM

Anemia: Clinical
Microcytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Macrocytic anemia: Pathology review
Myeloproliferative disorders: Pathology review
Myeloproliferative neoplasms: Clinical
Leukemias: Pathology review
Leukemia: Clinical
Lymphoma: Clinical
Plasma cell disorders: Pathology review
Plasma cell disorders: Clinical
Platelet disorders: Pathology review
Thrombocytopenia: Clinical
Bleeding disorders: Clinical
Thrombosis syndromes (hypercoagulability): Pathology review
Thrombophilia: Clinical
Peripheral vascular disease: Clinical
Venous thromboembolism: Clinical
Deep vein thrombosis and pulmonary embolism: Pathology review
Thrombolytics
Antiplatelet medications
Anticoagulants: Warfarin
Anticoagulants: Heparin
Anticoagulants: Direct factor inhibitors
Blood products and transfusion: Clinical
Vaccinations: Clinical
Pneumonia: Clinical
Abscesses
Infective endocarditis: Clinical
Skin and soft tissue infections: Clinical
Septic arthritis
Osteomyelitis
Fever of unknown origin: Clinical
Diarrhea: Clinical
Gastroenteritis
Clostridium difficile (Pseudomembranous colitis)
Urinary tract infections: Clinical
Sexually transmitted infections: Clinical
Meningitis, encephalitis and brain abscesses: Clinical
Clostridium tetani (Tetanus)
Clostridium botulinum (Botulism)
Salmonellosis
Shigella
Vibrio cholerae (Cholera)
Brucella
Mycobacterium tuberculosis (Tuberculosis)
Antituberculosis medications
Mycobacterium leprae
Treponema pallidum (Syphilis)
Leptospira
Upper respiratory tract infection
Pediatric upper airway conditions: Clinical
Pediatric lower airway conditions: Clinical
HIV (AIDS)
Herpes simplex virus
Varicella zoster virus
Herpesvirus medications
Epstein-Barr virus (Infectious mononucleosis)
Cytomegalovirus
Coccidioidomycosis and paracoccidioidomycosis
Aspergillus fumigatus
Mucormycosis
Plasmodium species (Malaria)
Antimalarials
Leishmania
Trypanosoma cruzi (Chagas disease)
Toxoplasma gondii (Toxoplasmosis)
Ascaris lumbricoides
Ancylostoma duodenale and Necator americanus
Strongyloides stercoralis
Enterobius vermicularis (Pinworm)
Anthelmintic medications
Bites and stings: Clinical
Cytomegalovirus infection after transplant (NORD)
Mechanisms of antibiotic resistance
Streptococcus pyogenes (Group A Strep)
Miscellaneous antifungal medications
Candida
Staphylococcus aureus
Pediatric infectious rashes: Clinical
ECG basics
ECG normal sinus rhythm
ECG rate and rhythm
ECG axis
ECG intervals
ECG QRS transition
ECG cardiac hypertrophy and enlargement
ECG cardiac infarction and ischemia
Atrial flutter
Atrial fibrillation
Premature atrial contraction
Atrioventricular nodal reentrant tachycardia (AVNRT)
Wolff-Parkinson-White syndrome
Ventricular tachycardia
Brugada syndrome
Premature ventricular contraction
Long QT syndrome and Torsade de pointes
Ventricular fibrillation
Atrioventricular block
Bundle branch block
Heart blocks: Pathology review
Pulseless electrical activity
Supraventricular arrhythmias: Pathology review
Ventricular arrhythmias: Pathology review
Heart failure
Heart failure: Pathology review
Heart failure: Clinical
Dilated cardiomyopathy
Restrictive cardiomyopathy
Hypertrophic cardiomyopathy
Cardiomyopathies: Clinical
Endocarditis
Myocarditis
Rheumatic heart disease
Tricuspid valve disease
Pulmonary valve disease
Mitral valve disease
Aortic valve disease
Valvular heart disease: Clinical
Pericarditis and pericardial effusion
Cardiac tamponade
Dressler syndrome
Pericardial disease: Clinical
Myocardial infarction
Coronary artery disease: Clinical
Renal artery stenosis
Hypertension: Clinical
Aortic aneurysms and dissections: Clinical
Pulmonary hypertension
Peripheral artery disease
Chronic venous insufficiency
Leg ulcers: Clinical
Congenital heart defects: Clinical
Lymphedema
Syncope: Clinical
Tuberculosis: Pathology review
Asthma: Clinical
Diffuse parenchymal lung disease: Clinical
Bronchiectasis
Obstructive lung diseases: Pathology review
Restrictive lung diseases: Pathology review
Lung cancer: Clinical
Pleural effusion: Clinical
Anatomy clinical correlates: Pleura and lungs
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
Sleep apnea
Respiratory distress syndrome: Pathology review
Acute respiratory distress syndrome: Clinical
Chronic obstructive pulmonary disease (COPD): Clinical
Pneumothorax: Clinical
Acute kidney injury: Clinical
Chronic kidney disease: Clinical
Nephritic and nephrotic syndromes: Clinical
Hypernatremia: Clinical
Hyponatremia: Clinical
Hyperkalemia: Clinical
Hypokalemia: Clinical
Parathyroid conditions and calcium imbalance: Clinical
Metabolic and respiratory alkalosis: Clinical
Metabolic and respiratory acidosis: Clinical
Kidney stones: Clinical
Esophageal disorders: Clinical
Esophageal surgical conditions: Clinical
Esophagitis: Clinical
Gastroesophageal reflux disease (GERD): Clinical
Peptic ulcers and stomach cancer: Clinical
Malabsorption syndromes: Pathology review
Inflammatory bowel disease: Clinical
Irritable bowel syndrome
Viral hepatitis: Clinical
Jaundice: Clinical
Cirrhosis: Clinical
Pancreatitis: Clinical
Alcohol-associated liver disease
Systemic lupus erythematosus (SLE): Clinical
Antiphospholipid syndrome
Rheumatoid arthritis: Clinical
Joint pain: Clinical
Scleroderma: Pathology review
Sjogren syndrome: Clinical
Seronegative arthritis: Clinical
Vasculitis: Clinical
Inflammatory myopathies: Clinical
Sarcoidosis
Gout and pseudogout: Pathology review
Antigout medications
Fibromyalgia
Hypopituitarism: Clinical
Thyroid nodules and thyroid cancer: Clinical
Hypothyroidism and thyroiditis: Clinical
Hyperthyroidism: Clinical
Adrenal masses and tumors: Clinical
Adrenal insufficiency: Clinical
Congenital adrenal hyperplasia: Clinical
MEN syndromes: Clinical
Cushing syndrome: Clinical
Pituitary adenomas and pituitary hyperfunction: Clinical
Diabetes mellitus: Clinical
Hypercholesterolemia: Clinical
Osteoporosis
Hemochromatosis
Seizures: Clinical
Cerebral vascular disease: Pathology review
Stroke: Clinical
Headaches: Clinical
Dementia and delirium: Clinical
Alzheimer disease
Parkinson disease
Hypokinetic movement disorders: Clinical
Hyperkinetic movement disorders: Clinical
Trigeminal neuralgia
Bell palsy
Multiple sclerosis
Guillain-Barre syndrome
Muscle weakness: Clinical
Myasthenia gravis
Lambert-Eaton myasthenic syndrome
Shock: Clinical
Disorders of consciousness: Clinical
Subarachnoid hemorrhage

Transcript

Watch video only

Content Reviewers

Mycobacterium leprae is a rod-shaped bacteria which was first discovered in 1873 by Hansen.

Mycobacterium leprae is a non tuberculous mycobacteria and it causes a disease called leprosy, or Hansen disease. In US, the animal reservoir for Mycobacterium leprae are armadillos.

Now, Mycobacterium leprae it’s an acid-fast bacillus which means it’s resistant to decolorization by acids and it has a high content of mycolic acid in its cell wall, which makes it waxy, hydrophobic and impermeable to routine stain such as Gram stain.

So, it needs special staining methods to be visualized such as Ziehl-Neelsen staining which uses carbol fuchsin combined with phenol which is able to penetrate the waxy mycobacterial cell wall.

So, the stain binds to the mycolic acid in the mycobacterial cell wall and after staining, an acid decolorizing solution is applied which removes the red dye from the background cells, tissue fibres, and any organisms in the smear except Mycobacteria, which retain the dye.

So Mycobacterium leprae appears bright red on a blue background. Other staining methods can be used such as Kinyoun staining, in which the bacteria appear bright red on a green background and fluorescence microscopy using specific fluorescent dyes such as auramine-rhodamine stain.

Now, Mycobacterium leprae is an obligate intracellular microorganism, which means it can survive only inside cells, and it’s an obligate aerobe which means it can survive only in the presence of oxygen.

Finally, Mycobacterium leprae grows best at cool temperatures, between 27 to 33 degrees Celsius, and it proliferates slowly and it cannot be cultivated in vitro.

Instead, it can be inoculated in nine-banded armadillos, which have a much lower body temperature than most mammals and, like humans, are susceptible to leprosy.

Now, Mycobacterium leprae can enter the body through the lungs or broken skin.

Once inside the body, it goes for regions in which the temperature is lower than the rest of the body such as skin, peripheral nerves and mucosa of the upper respiratory tract.

So, the bacteria goes for the Schwann cells of peripheral nerves.

These cells wrap their plasma membrane around peripheral nerve axons forming the myelin sheath.

This is possible because of a virulence factor, called phenolic glycolipid 1, or PGL-1 for short, which attaches to a protein called laminin-2 which is found on the Schwann cells.

Binding to Schwann cells induces demyelination, affecting transmission of the electrical impulses through the nerve axon, and causing nerve injury.

Additionally, Mycobacterium leprae can also infect skin macrophages.

So, the bacteria is ingested by macrophages and wrapped up in a vesicle called a phagosome, which would normally merge with another intracellular organelle called a lysosome.

Inside the phagolysosome, the bacteria would normally be destroyed.

But, Mycobacterium leprae has the ability to inhibit the phagolysosomal fusion, which allows the bacteria to survive inside macrophages and replicate there.

Now, the host responds to leprosy through cell mediated immunity via T-helper cells.

These cells help the activity of other immune cells by releasing T cell cytokines, and there are two types of T-helper cells - Th1 and Th2.

Depending on which T-helper cells are involved in the immune response, there are two major forms of leprosy - lepromatous and tuberculoid.

Now, in the lepromatous form, the infection induces a Th2 cell response, and Th2 cells secrete IL-4, IL-5 and IL-10.

These molecules are cytokines, which means that they signal B cells to make antibodies against Mycobacterium leprae, so this is a type of humoral, antibody-based response.

Now, this response is not effective in killing intracellular pathogens like Mycobacterium leprae, that can escape humoral immune mechanisms and replicate inside macrophages.

So, the inefficient immune response seen in the lepromatous form is sometimes also called a low cell mediated immunity response.

This leads to extensive skin involvement and symmetric nerve involvement, and the lepromatous form is also called multibacillary leprosy because of the large number of bacteria found in the lesions.

On the other hand, with is tuberculoid form, the infection induces a Th1 response, and Th1 cells secrete IL-2 and interferon-gamma.

Key Takeaways

Mycobacterium leprae is a species of acid fast bacillus, obligate intracellular, aerobic bacteria, which primarily causes leprosy, a chronic and disfiguring skin disease. It is spread from person to person through contact with nasal secretions and skin lesions and can cause nerve damage and other organ damage if left untreated.

The diagnosis involves identifying Mycobacterium leprae bacteria in a skin biopsy with microscopy or PCR. Treatment typically involves a combination of antibiotics, such as dapsone or rifampin, and other drugs such as clofazimine or prednisone.